绝经后女性冠心病患者中性粒细胞/淋巴细胞比值与冠状动脉病变程度的相关性研究

刘伟倩, 齐晓勇. 绝经后女性冠心病患者中性粒细胞/淋巴细胞比值与冠状动脉病变程度的相关性研究[J]. 临床心血管病杂志, 2019, 35(4): 370-373. doi: 10.13201/j.issn.1001-1439.2019.04.018
引用本文: 刘伟倩, 齐晓勇. 绝经后女性冠心病患者中性粒细胞/淋巴细胞比值与冠状动脉病变程度的相关性研究[J]. 临床心血管病杂志, 2019, 35(4): 370-373. doi: 10.13201/j.issn.1001-1439.2019.04.018
LIU Weiqian, QI Xiaoyong. Correlation between neutrophil to lymphocyte ratio and coronary artery lesions in postmenopausal female patients with coronary artery disease[J]. J Clin Cardiol, 2019, 35(4): 370-373. doi: 10.13201/j.issn.1001-1439.2019.04.018
Citation: LIU Weiqian, QI Xiaoyong. Correlation between neutrophil to lymphocyte ratio and coronary artery lesions in postmenopausal female patients with coronary artery disease[J]. J Clin Cardiol, 2019, 35(4): 370-373. doi: 10.13201/j.issn.1001-1439.2019.04.018

绝经后女性冠心病患者中性粒细胞/淋巴细胞比值与冠状动脉病变程度的相关性研究

详细信息
    通讯作者: 齐晓勇,E-mail:hbghxiaoyong-q@126.com
  • 中图分类号: R541.4

Correlation between neutrophil to lymphocyte ratio and coronary artery lesions in postmenopausal female patients with coronary artery disease

More Information
  • 目的:探讨绝经后女性冠心病患者的中性粒细胞/淋巴细胞比值(NLR)与冠状动脉(冠脉)病变程度的关系。方法:收集经冠脉造影确诊的女性冠心病患者226例,根据NLR值分为NLR低值组(110例)和NLR高值组(116例)。记录Gensini积分,探讨NLR与冠脉病变程度的关系。结果:与NLR低值组的Gensini积分(38.07±29.50)比较,NLR高值组Gensini积分(47.45±34.91)较高,差异有统计学意义(P<0.05)。运用双变量相关分析发现,Gensini积分与NLR呈正相关(r=0.206,P<0.05)。结论:与NLR低值组相比,NLR高值组的冠脉病变程度较严重,冠脉严重程度与NLR呈正相关。
  • 加载中
  • [1]

    王贵荣.女性冠心病研究进展[J].黑龙江医学, 2016, 10(40):969-971.

    [2]

    张秀连, 孟军.性激素补充治疗与冠心病相关危险因素的研究[J].实用中西医结合临床, 2016, 16(3):86-89.

    [3]

    Dosi R, Bhatt N, Shah P, et al.Cardiovascular disease and menopause[J].J Clin Diagn Res, 2014, 8(2):62-64.

    [4]

    尔璐, 侯曜曜, 张永亮, 等.绝经前后女性冠心病患者HDL及LDL颗粒与冠状动脉病变程度的相关性研究[J].中国动脉硬化杂志, 2017, 25(8):823-829.

    [5]

    Chen L, Li Q, Yang Z, et al.Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese[J].Diabet Med, 2013, 30(3):309-317.

    [6]

    Bhat T, Teli S, Rijal J, et al.Neutrophil to lymphocyte ratio and cardiovascular diseases:a review[J].Expert Rev Cardiovasc Ther, 2013, 11(1):55-59.

    [7]

    Torun S, Tunc BD, Suvak B, et al.Assessment of neutrophil-lymphocyte ratio in ulcerative colitis:a promising marker in predicting disease severity[J].Clin Res Hepatol Gastroenterol, 2012, 36(5):491-497.

    [8]

    Acet H, Erta F, Akll MA, et al.Novel predictors of infarct related artery patency for ST-segment elevation myocardial infarction:platelet to lymphocyte ratio, uric acid, and neutrophil to lymphocyte ratio[J].Anatol J Cardiol, 2015, 15(8):648-656.

    [9]

    Kurtul S, Sarli B, Baktir AO, et al.Neutrophil to lymphocyte ratio predicts SYNTAX score in patients with non-ST segment elevation myocardial infarction[J].Int Heart J, 2015, 56(1):18-21.

    [10]

    Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol, 1983, 51(3):606-607.

    [11]

    Meyer MR, Barton M.Estrogens and coronary artery disease:new clinicalperspectives[J].Adv Pharmacol, 2016, 77:307-360.

    [12]

    Yan L, Cao X, Zeng S, et al.Associations of proteins relevant MAPK signaling pathway(p38MAPK-1, HIF-1 and HO-1) with coronary lesion characteristics and prognosis of peri-menopausal women[J].Lipids Health Dis, 2016, 15(1):187-187.

    [13]

    Manson JE, Chlebowski RT, Stefanick ML, et al.Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiativerandomized trials[J].JAMA, 2013, 310(13):1353-1368.

    [14]

    Boardman HM, Hartley L, Eisinga A, et al.Hormone therapy for preventing cardiovascular disease in post-menopausal women[J].Cochrane Database Syst Rev, 2015, 10(3):CD002229.

    [15]

    Vittinghoff E, Shlipak MG, Varosy PD, et al.Risk factors and secondary prevention in women wish heart disease:the heart with heart disease:the heart and estrogen/progestin replacement study[J].Ann Intern Med, 2003, 138(2):81-89.

    [16]

    Hulley S, Furberg C, Barrett-Connor E, et al.Noncardiovascular disease outcomes during 6.8 years of hormone therapy:Heart and Estrogen/progestin Replacement Study follow-up(HERSⅡ)[J].JAMA, 2002, 288(1):58-66.

    [17]

    Ohira T, Folsom AR, Cushman M, et al.Reproductive history, hormone replacement, and incidence of venous thromboembolism:the longistudinal investigation of thromboembolism Etiology[J].Br Haematol, 2010, 149(4):606-612.

    [18]

    Rossouw JE, Anderson GL, Prentice RL, et al.Risk and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the women's health initiative randomized controlled trial[J].JAMA, 2002, 288(3):321-333.

    [19]

    李秋儒.围绝经期女性ST-T改变的临床分析56例[J].实用妇科内分泌电子杂志, 2014, 1(3):13-14.

    [20]

    董海秋, 董梅, 任法新.雌激素水平对绝经后女性急性心肌梗死发生的影响研究[J].临床心血管病杂志, 2017, 33(2):56-59.

    [21]

    Azab B, Bhatt VR, Phookan J, et al.Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients[J].Ann Surg Oncol, 2012, 19(1):217-224.

    [22]

    Shah N, Parikh V, Patel N, et al.Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction ofcoronary heart disease mortality:insights from the National Healthand Nutrition Examination Survey-Ⅲ[J].Int J Cardiol, 2014, 171(3):390-397.

    [23]

    Bekler A, Erbag G, Sen H, et al.Predictive value of elevated neutrophil-lymphocyte ratio for left ventricular systolic dysfunction in patients with non ST-elevated acute coronary syndrome[J].Pak J Med Sci, 2015, 31(1):159-163.

    [24]

    蔡莉娜, 杨文博, 强红丽, 等.393例女性冠心病患者的临床特征及预后探讨[J].临床心血管病杂志, 2018, 34(9):876-879.

  • 加载中
计量
  • 文章访问数:  118
  • PDF下载数:  49
  • 施引文献:  0
出版历程
收稿日期:  2018-07-08

目录